Related references
Note: Only part of the references are listed.Opioid agonist treatment is highly protective against overdose death among a US statewide population of justice-involved adults
Noa Krawczyk et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2021)
Increases in methamphetamine use among heroin treatment admissions in the United States, 2008-17
Christopher M. Jones et al.
ADDICTION (2020)
Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services
Noa Krawczyk et al.
ADDICTION (2020)
Private Coverage of Methadone in Outpatient Treatment Programs
Daniel Polsky et al.
PSYCHIATRIC SERVICES (2020)
Opioid overdose death following criminal justice involvement: Linking statewide corrections and hospital databases to detect individuals at highest risk
Noa Krawczyk et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States
Andrew S. Huhn et al.
JAMA NETWORK OPEN (2020)
Association between methamphetamine use and retention among patients with opioid use disorders treated with buprenorphine
Judith Tsui et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2020)
Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update
C. Holly A. Andrilla et al.
JOURNAL OF RURAL HEALTH (2019)
Development of a Cascade of Care for responding to the opioid epidemic
Arthur Robin Williams et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2019)
Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential - United States, 2003-2017
Mbabazi Kariisa et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2019)
Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured to cohort
Jake R. Morgan et al.
DRUG AND ALCOHOL DEPENDENCE (2019)
Challenges on the road to recovery: Exploring attitudes and experiences of clients in a community-based buprenorphine program in Baltimore City
C. Truong et al.
ADDICTIVE BEHAVIORS (2019)
Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities
Ramin Mojtabai et al.
HEALTH AFFAIRS (2019)
Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap
Noa Krawczyk et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2019)
Prescribing decisions at buprenorphine treatment initiation: Do they matter for treatment discontinuation and adverse opioid-related events?
Angelica Meinhofer et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2019)
Excess overdose mortality immediately following transfer of patients and their care as well as after cessation of opioid substitution therapy
Karolina M. Bogdanowicz et al.
ADDICTION (2018)
Extended-release injectable naltrexone for opioid use disorder: a systematic review
Brantley P. Jarvis et al.
ADDICTION (2018)
A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees
Bradley D. Stein et al.
SUBSTANCE ABUSE (2018)
Overcoming medication stigma in peer recovery: A new paradigm
Noa Krawczyk et al.
SUBSTANCE ABUSE (2018)
The Next Stage of Buprenorphine Care for Opioid Use Disorder
Stephen A. Martin et al.
ANNALS OF INTERNAL MEDICINE (2018)
Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees
Hillary Samples et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2018)
Developing an opioid use disorder treatment cascade: A review of quality measures
Arthur Robin Williams et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2018)
Extended-release naltrexone for opioid use disorder started during or following incarceration
Thomas Lincoln et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2018)
Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population
Jake R. Morgan et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2018)
Only One In Twenty Justice-Referred Adults In Specialty Treatment For Opioid Use Receive Methadone Or Buprenorphine
Noa Krawczyk et al.
HEALTH AFFAIRS (2017)
Patterns of Buprenorphine-Naloxone Treatment for Opioid Use Disorder in a Multistate Population
Brendan Saloner et al.
MEDICAL CARE (2017)
'When you are homeless, you are not thinking about your medication, but your food, shelter or heat for the night': behavioural determinants of homeless patients' adherence to prescribed medicines
V. Paudyal et al.
PUBLIC HEALTH (2017)
Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a US national sample
Noa Krawczyk et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
Commercial Health Plan Coverage of Selected Treatments for Opioid Use Disorders from 2003 to 2014
Sharon Reif et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2017)
The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a US national sample
Noa Krawczyk et al.
DRUG AND ALCOHOL DEPENDENCE (2017)
Retention in medication-assisted treatment for opiate dependence: A systematic review
Christine Timko et al.
JOURNAL OF ADDICTIVE DISEASES (2016)
Non-Prescribed Buprenorphine in New York City: Motivations for Use, Practices of Diversion, and Experiences of Stigma
Bennett Allen et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2016)
Evaluating racial disparity in referral source and successful completion of substance abuse treatment
Ethan Sahker et al.
ADDICTIVE BEHAVIORS (2015)
Geographic and Specialty Distribution of US Physicians Trained to Treat Opioid Use Disorder
Roger A. Rosenblatt et al.
ANNALS OF FAMILY MEDICINE (2015)
Buprenorphine pharmacotherapy and behavioral treatment: Comparison of outcomes among prescription opioid users, heroin users and combination users
Suzanne Nielsen et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2015)
Predictors of Patient Retention in Methadone Maintenance Treatment
Steven L. Proctor et al.
PSYCHOLOGY OF ADDICTIVE BEHAVIORS (2015)
Gender-Specific Predictors of Retention and Opioid Abstinence During Methadone Maintenance Treatment
Amanda R. Levine et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2015)
Discontinuation of Buprenorphine Maintenance Therapy: Perspectives and Outcomes
Brandon S. Bentzley et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2015)
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
Yih-Ing Hser et al.
ADDICTION (2014)
A Comparison of Characteristics and Outcomes of Opioid-Dependent Patients Initiating Office-Based Buprenorphine or Methadone Maintenance Treatment
Michael I. Fingerhood et al.
SUBSTANCE ABUSE (2014)
Primary Care-Based Buprenorphine Taper vs Maintenance Therapy for Prescription Opioid Dependence A Randomized Clinical Trial
David A. Fiellin et al.
JAMA INTERNAL MEDICINE (2014)
Access to Treatment for Opioid Dependence in Rural America Challenges and Future Directions
Stacey C. Sigmon
JAMA PSYCHIATRY (2014)
Emerging adult age status predicts poor buprenorphine treatment retention
Zev Schuman-Olivier et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2014)
Health Outcomes and Retention in Care Following Release from Prison for Patients of an Urban Post-incarceration Transitions Clinic
Aaron D. Fox et al.
JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED (2014)
Leaving buprenorphine treatment: Patients' reasons for cessation of care
Jan Gryczynski et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2014)
Blacks And Hispanics Are Less Likely Than Whites To Complete Addiction Treatment, Largely Due To Socioeconomic Factors
Brendan Saloner et al.
HEALTH AFFAIRS (2013)
Predictors of methadone program non-retention for opioid analgesic dependent patients
Joseph Cox et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2013)
HOUSING FIRST FOR SEVERELY MENTALLY ILL HOMELESS METHADONE PATIENTS
Philip W. Appel et al.
JOURNAL OF ADDICTIVE DISEASES (2012)
Methadone as Social Control: Institutionalized Stigma and the Prospect of Recovery
Julie Harris et al.
QUALITATIVE HEALTH RESEARCH (2012)
Predictors of methadone treatment retention from a multi-site study: A survival analysis
Sharon M. Kelly et al.
DRUG AND ALCOHOL DEPENDENCE (2011)
Multiple imputation using chained equations: Issues and guidance for practice
Ian R. White et al.
STATISTICS IN MEDICINE (2011)
Distance Traveled and Cross-State Commuting to Opioid Treatment Programs in the United States
Andrew Rosenblum et al.
JOURNAL OF ENVIRONMENTAL AND PUBLIC HEALTH (2011)
Risk of drug-related mortality during periods of transition in methadone maintenance treatment: A cohort study
Grainne Cousins et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2011)
Meta-analysis of drug-related deaths soon after release from prison
Elizabeth L. C. Merrall et al.
ADDICTION (2010)
A Meta-Analysis of Retention in Methadone Maintenance by Dose and Dosing Strategy
Yan-ping Bao et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2009)
Premature Discharge from Methadone Treatment: Patient Perspectives
Heather Schacht Reisinger et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2009)
Mortality prior to, during and after opioid maintenance treatment (OMT): A national prospective cross-registry study
Thomas Clausen et al.
DRUG AND ALCOHOL DEPENDENCE (2008)
Methadone maintenance vs. methadone taper during pregnancy: Maternal and neonatal outcomes
Hendree E. Jones et al.
AMERICAN JOURNAL ON ADDICTIONS (2008)
Slow tapering from methadone maintenance in a program encouraging indefinite maintenance
DA Calsyn et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2006)
From opioid maintenance to abstinence: a literature review
H Kornor et al.
DRUG AND ALCOHOL REVIEW (2005)
Retention in publicly funded methadone maintenance treatment in two Western states
D Deck et al.
JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH (2005)
Share Paper
